Skip to main content
. 2018 Jan;21(1):33–38. doi: 10.22038/IJBMS.2017.18840.5029

Figure 3.

Figure 3

The serum levels of inflammatory cytokines were decreased by protosappanin A. Compared with the model control, levels of MMP-9 (A), IL-6 (B) and TNF-α (C) were decreased in rosuvastatin treatment groups (positive control), and were also decreased in PrA treatment groups in a dose dependent manner. n=12, mean±SD. **P<0.01, ***P<0.001 vs. model control; ###P<0.001 vs. positive control (Rosuvastatin group)